Drug Channels Leadership Forum to Address Future Trends and Challenges in Healthcare

Drug Channels Leadership Forum

MALVERN, PA — The Drug Channels Leadership Forum (DCLF), organized by the Drug Channels Institute (DCI), an HMP Global company, is set to take place from March 17 to 19, 2025, at the Turnberry Resort and Spa in Miami. This highly anticipated event will bring together top executives from across the healthcare industry to discuss pressing issues and emerging trends that are shaping the future of U.S. drug channels.

The forum’s agenda is packed with engaging topics that delve into strategic uncertainties and challenges confronting the healthcare system. Adam J. Fein, Ph.D., president of DCI, emphasized the importance of the event, stating, “Through the Drug Channels Leadership Forum, executives will be able to connect and address the critical issues and challenges confronting the commercial healthcare system.” Dr. Fein is known for his expertise in pharmaceutical economics and his ability to unravel complex business issues with clarity.

One of the key features of DCLF is its format, which includes salon-style discussions, fireside chats, and panel sessions, allowing participants to engage in one-on-one conversations with industry leaders. These sessions are designed to provide insights into pharmaceutical distribution, reimbursement systems, and future trends in the healthcare sector.

On March 18, a series of fireside chats will feature prominent figures such as Steven H. Collis, chairman, president, and CEO of Cencora, Inc., at 9:15 a.m.; David Joyner and Prem Shah from CVS Health at 1 p.m.; and Tim Wentworth, CEO of Walgreens Boots Alliance, Inc., at 4:30 p.m. The following day, Frank Cunningham from Eli Lilly and Company will participate in a chat at 11 a.m.

READ:  Harmony Biosciences to Join Fireside Chat at Oppenheimer Rare Disease Summit

Dr. Fein will moderate these discussions, ensuring they are both informative and engaging. His ability to simplify complex topics will be crucial in dissecting the intricate issues facing the sector.

In addition to the fireside chats, the forum will host dynamic panel discussions. On March 18, “Wall Street Controversies on Drug Channel Companies” will feature insights from top Wall Street analysts. Later that day, “Crossfire: PBMs and Pharmacies” will see experts debating the evolving roles of pharmacy benefit managers and pharmacies. Another highlight is the session titled “What’s Next for HUB Services and Patient Assistance?” which will explore innovations in patient support services.

The agenda also includes discussions on technological disruptions in the drug channel and the future of pharmacy services. Notably, the panel “Pharmacy: The Next Generation” will convene industry leaders to discuss the upcoming evolution in pharmacy practice.

“These candid and thought-provoking conversations with industry leaders will pinpoint the factors that will improve U.S. healthcare,” Dr. Fein added, underscoring the forum’s potential to drive positive change in the industry.

The DCLF is tailored for executives from various sectors, including pharmaceutical manufacturers, pharmacy benefit managers, health plans, insurers, and government agencies. Attendees will gain valuable knowledge and network with peers, all while contributing to the advancement of healthcare solutions in a rapidly evolving landscape.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.